Home Health & Wellness New Study Highlights Potential Benefits of Catheter Ablation in Reducing Dementia Risk for Atrial Fibrillation Patients

New Study Highlights Potential Benefits of Catheter Ablation in Reducing Dementia Risk for Atrial Fibrillation Patients

Reading Time: 2 minutes

A new study has found a significant link between catheter ablation (CA) and a reduced risk of dementia among patients with atrial fibrillation (AF). Published in the journal Current Problems in Cardiology, the systematic review and meta-analysis examined data from multiple studies to assess whether CA could lower the likelihood of developing dementia in AF patients. This research adds to the growing body of evidence suggesting that treating AF with CA may have broader health benefits beyond heart rhythm control.

Atrial fibrillation, a common type of cardiac arrhythmia, is already associated with an increased risk of dementia. AF can lead to silent cerebral infarctions, which occur without overt stroke symptoms but can cause significant cognitive impairment over time. The underlying mechanisms are complex and may include reduced cerebral blood flow, microemboli, and systemic inflammation. Previous studies have demonstrated that patients with AF are at higher risk of developing both Alzheimer’s disease and vascular dementia.

The study, led by Vikash Jaiswal and colleagues, systematically reviewed and analysed data from five studies encompassing 125,649 patients, with 30,192 in the CA group and 95,457 in the non-CA group. The researchers utilised hazard ratios (HR) to evaluate the risk of dementia among patients who underwent CA compared to those who did not.

Patients who underwent CA showed a significantly lower risk of developing dementia compared to those who did not undergo the procedure. The risk of Alzheimer’s disease was also lower in the CA group. No statistically significant difference was observed in the risk of vascular dementia between the CA and non-CA groups.

The study highlighted that while CA appears beneficial in reducing the overall risk of dementia and Alzheimer’s disease, its impact on vascular dementia remains uncertain.

The mechanisms by which CA might reduce dementia risk are not entirely understood. But several hypotheses have been proposed. CA is known to restore and maintain normal heart rhythm, potentially improving cerebral perfusion and reducing the risk of silent cerebral infarctions. Some studies have also suggested that maintaining sinus rhythm through CA could prevent the cognitive decline associated with AF.

Additionally, near-infrared spectroscopy has shown that CA can mitigate reduced frontal and temporal brain activity observed in AF patients, which might contribute to cognitive improvements. The overall benefits of CA in AF patients extend beyond heart health, suggesting a possible protective effect against cognitive decline and dementia.

Despite these promising findings, the study acknowledges several limitations. Most data were derived from observational studies, which can be prone to confounding biases. The study’s authors also noted the inability to perform subgroup analyses to further evaluate the effects of follow-up duration, gender, and age differences.

© Copyright 2014–2034 Psychreg Ltd